| “… he preferred not to have a portacath” |
Patient |
| “She is not keen to have intravenous treatment” |
Patient |
| “He was not keen to have infusional chemotherapy in the beginning and his difficulty with mobility and discomfort with long waits has further convinced him so” |
Patient |
| “… there is ample data to suggest it is equivalent and possibly better tolerated and certainly far less cumbersome for the patient leading to other cost savings in terms of time spent in chemotherapy administration” |
One option discussed |
| “… he is not very keen (…) as he does not want to take time off work to allow for the 2 days that he will need to attend every fortnight” |
Patient |
| “We have advised that he receive oral capecitabine, concurrent with the radiotherapy, as this tends to be better tolerated than intravenous 5-fluorouracil (5-FU)” |
Physician recommended |
| “I thought it was reasonable to offer her palliative systemic chemotherapy but, in an attempt to reduce the risk of significant toxicity, I thought it appropriate to start with single agent oral 5-fluorouracil analogue capecitabine” |
Physician |
| “In view of the equal efficacy of both the agents the patient would prefer, from a convenience point of view, to have treatment with capecitabine” |
Patient |
| “… given the fact that she already has metastasis, she is eligible for the oral version of analogue of 5-fluorouracil capecitabine” |
Physician |
